Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$187K Buy
16,307
+1,930
+13% +$23K ﹤0.01% 1589
2025
Q4
$165K Sell
14,377
-50
-0.3% -$517 ﹤0.01% 1461
2025
Q3
$130K Sell
14,427
-12
-0.1% -$102 ﹤0.01% 1591
2025
Q2
$100K Buy
14,439
+8
+0.1% +$51 ﹤0.01% 1562
2025
Q1
$81K Buy
14,431
+2,505
+21% +$15.2K ﹤0.01% 1526
2024
Q4
$67.3K Hold
11,926
﹤0.01% 1517
2024
Q3
$72.7K Hold
11,926
﹤0.01% 1470
2024
Q2
$76.2K Sell
11,926
-685
-5% -$5.24K ﹤0.01% 1396
2024
Q1
$114K Buy
+12,611
New +$101K ﹤0.01% 1383
2020
Q2
Sell
-15,240
Closed -$32K 1270
2020
Q1
$32K Hold
15,240
﹤0.01% 1166
2019
Q4
$58K Hold
15,240
﹤0.01% 1254
2019
Q3
$60K Buy
15,240
+500
+3% +$1.83K ﹤0.01% 1230
2019
Q2
$62K Buy
+14,740
New +$65.8K ﹤0.01% 1276
2017
Q1
Sell
-29,280
Closed -$226K 1297
2016
Q4
$226K Buy
+29,280
New +$233K 0.01% 1113
2014
Q4
Sell
-45,371
Closed -$526K 1416
2014
Q3
$526K Sell
45,371
-18,996
-30% -$221K 0.02% 831
2014
Q2
$758K Sell
64,367
-79,941
-55% -$909K 0.02% 712
2014
Q1
$1.56M Buy
+144,308
New +$1.56M 0.05% 450

Other funds holding CX

Oppenheimer & Co's CX Position: Q1 2026 in Review

Oppenheimer & Co increased its Cemex (CX) stake by 13% in Q1 2026, buying an estimated $23K and bringing the position to 16,307 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Oppenheimer & Co first reported a position in CX in Q1 2014 and has held it in 17 quarters since. The position peaked at $1.56M in Q1 2014. 311 funds tracked by Wall St. Rank hold CX as of Q1 2026.

  • Oppenheimer & Co held 16,307 shares of Cemex worth $187K as of Q1 2026.
  • Oppenheimer & Co bought 1,930 Cemex shares in Q1 2026, an estimated $23K.
  • Cemex made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1589 holding.
  • Oppenheimer & Co first reported a position in Cemex in Q1 2014 and has held it in 17 quarters since.
  • Oppenheimer & Co's Cemex position peaked at $1.56M in Q1 2014.
  • 311 funds tracked by Wall St. Rank held Cemex as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.